Oliguria, volume overload, and loop diuretics

Critical Care Medicine

Volumn 36, Issue SUPPL. 4, 2008, Pages

  Bagshaw, Sean M ^a   Bellomo, Rinaldo ^b   Kellum, John A ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Acute renal failure; Critically ill; Equipoise; Fluid therapy; Furosemide; Loop diuretic; Oliguria; Randomized trial; Resuscitation

Indexed keywords

BOLDENONE UNDECENOATE; DOPAMINE; FUROSEMIDE; LOOP DIURETIC AGENT; MANNITOL; TORASEMIDE;

CLINICAL PRACTICE; CLINICAL TRIAL; DRUG DOSE TITRATION; FLUID THERAPY; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; KIDNEY INJURY; OLIGURIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; TINNITUS;

EID: 41649108493     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318168c92f     Document Type: Review

References (94)

1. Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294:813-818
2. Bagshaw SM, George C, Bellomo R: Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 2007; 11:R68
3. Bagshaw SM, Laupland KB, Doig CJ, et al: Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care 2005; 9:R700-R709
4. Brivet FG, Kleinknecht DJ, Loirat P, et al: Acute renal failure in intensive care units- causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996; 24:192-198
5. de Mendonca A, Vincent JL, Suter PM, et al: Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26:915-921
6. Liano F, Junco E, Pascual J, et al: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998; 66:S16-S24
7. Mehta RL, Pascual MT, Soroko S, et al: Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 2004; 66:1613-1621
8. Metnitz PG, Krenn CG, Steltzer H, et al: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058
9. Morgera S, Kraft AK, Siebert G, et al: Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002; 40:275-279
10. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29:1910-1915
11. Korkeila M, Ruokonen E, Takala J: Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000; 26:1824-1831
12. Manns B, Doig CJ, Lee H, et al: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 2003; 31:449-455
13. Abel RM, Beck CH Jr, Abbott WM, et al: Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose: Results of a prospective, double-blind study. N Engl J Med 1973; 288:695-699
14. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
15. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-310
16. Guerin C, Girard R, Selli JM, et al: Initial versus delayed acute renal failure in the intensive care unit: A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 2000; 161:872-879
17. Liangos O, Rao M, Balakrishnan VS, et al: Relationship of urine output to dialysis initiation and mortality in acute renal failure. Nephron Clin Pract 2005; 99:c56-c60
18. Klahr S, Miller SB: Acute oliguria. N Engl J Med 1998; 338:671-675
19. Sladen RN: Prevention of perioperative renal failure. Anesth Analg 2005; 100(3 Suppl):78-88
20. DePriest J: Reversing oliguria in critically ill patients. Postgrad Med 1997; 102:245-246, 251-242, 258 passim
21. Vanholder R, De Smet R, Glorieux G, et al: Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003; 63:1934-1943
22. Vanholder R, Glorieux G, Lameire N: New insights in uremic toxicity. Contrib Nephrol 2005; 149:315-324
23. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
24. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
25. Lin SM, Huang CD, Lin HC, et al: A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial. Shock 2006; 26:551-557
26. Shapiro NI, Howell MD, Talmor D, et al: Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006; 34:1025-1032
27. Pinsky MR: Goals of resuscitation from circulatory shock. Contrib Nephrol 2004; 144:94-104
28. Sakr Y, Vincent JL, Reinhart K, et al: High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest 2005; 128:3098-3108
29. Van Biesen W, Yegenaga I, Vanholder R, et al: Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: A prospective analysis. J Nephrol 2005; 18:54-60
30. Wiedemann HP, Wheeler AP, Bernard GR, et al: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
31. Simmons RS, Berdine GG, Seidenfeld JJ, et al: Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 1987; 135:924-929
32. Uchino S, Bellomo R, Morimatsu H, et al: Pulmonary artery catheter versus pulse contour analysis: A prospective epidemiological study. Crit Care 2006; 10:R174
33. Hoste EA, Kellum JA: Acute renal failure in the critically ill: Impact on morbidity and mortality. Contrib Nephrol 2004; 144:1-11
34. Brandstrup B: Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 2006; 20:265-283
35. Perko MJ, Jarnvig IL, Hojgaard-Rasmussen N, et al: Electric impedance for evaluation of body fluid balance in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15:44-48
36. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al: Effects of intravenous fluid restriction on postoperative complications: Comparison of two perioperative fluid regiments. A randomized assessor-blinded multicentre trial. Ann Surg 2003; 238:641-648
37. Nisanevich V, Felsenstein I, Almogy G, et al: Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005; 103:25-32
38. Liu KD, Matthay MA, Chertow GM: Evolving practices in critical care and potential implications for management of acute kidney injury. Clin J Am Soc Nephrol 2006; 1:869-873
39. Finfer S, Bellomo R, Boyce N, et al: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
40. Cittanova ML, Leblanc I, Legendre C, et al: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348:1620-1622
41. Cittanova ML, Mavre J, Riou B, et al: Longterm follow-up of transplanted kidneys according to plasma volume expander of kidney donors. Intensive Care Med 2001; 27:1830
42. Schortgen F, Lacherade JC, Bruneel F, et al: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357:911-916
43. Bagshaw SM, Delaney A, Jones D, et al: Diuretics in the management of acute kidney injury: A multinational survey. Contrib Nephrol 2007; 156:236-249
44. Mehta RL, Pascual MT, Soroko S, et al: Diuretics, mortality, and nonrecovery of renal function in acute renal failure [see comment]. JAMA 2002; 288:2547-2553
45. Uchino S, Doig GS, Bellomo R, et al: Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32:1669-1677
46. DeTorrente A, Miller PD, Cronin RE, et al: Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol 1978; 235:F131-F136
47. Kramer HJ, Schuurmann J, Wassermann C, et al: Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int 1980; 17:455-464
48. Heyman SN, Rosen S, Epstein FH, et al: Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int 1994; 45:981-985
49. Aravindan N, Aravindan S, Riedel BJ, et al: Furosemide prevents apoptosis and associated gene expression in a rat model of surgical ischemic acute renal failure. Ren Fail 2007; 29:399-407
50. Aravindan N, Shaw A: Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail 2006; 28:25-35
51. Oppermann M, Hansen PB, Castrop H, et al: Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am J Physiol Renal Physiol 2007; 293:F279-F287
52. Pedersen M, Vajda Z, Stodkilde-Jorgensen H, et al: Furosemide increases water content in renal tissue. Am J Physiol Renal Physiol 2007; 292:F1645-F1651
53. Costa MA, Loria A, Elesgaray R, et al: Role of nitric oxide pathway in hypotensive and renal effects of furosemide during extracellular volume expansion. J Hypertens 2004; 22:1561-1569
54. Costa MA, Marchetti M, Balaszczuk AM, et al: Effects of L-arginine and furosemide on blood pressure and renal function in volume-expanded rats. Clin Exp Pharmacol Physiol 2001; 28:528-532
55. Croce M, Costa Manso E, Gato JJ, et al: Furosemide inhibits in vitro histamine release induced by antigens and anti-IgE. J Investig Allergol Clin Immunol 1992; 2:205-210
56. Heyman SN, Brezis M, Greenfeld Z, et al: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 1989; 14:377-385
57. De Torrente A, Miller PD, Cronin RE, et al: Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol 1978; 235:F131-F136
58. Hanley MJ, Davidson K: Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. Am J Physiol 1981; 241:F556-F564
59. Papadimitriou M, Milionis A, Sakellariou G, et al: Effect of furosemide on acute ischaemic renal failure in the dog. Nephron 1978; 20:157-162
60. Yuengsrigul A, Chin TW, Nussbaum E: Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells. Ann Allergy Asthma Immunol 1999; 83:559-566
61. Beroniade V: Furosemide in acute and chronic renal failure. Dial Renal Transplant 1969; 5:241-245
62. Borirakchanyavat V, Vongsthongsri M, Sitprija V: Furosemide and acute renal failure. Postgrad Med J 1978; 54:30-32
63. Brown CB, Ogg CS, Cameron JS: High dose frusemide in acute renal failure: A controlled trial. Clin Nephrol 1981; 15:90-96
64. Brown CB, Ogg CS, Cameron JS, et al: High dose frusemide in acute reversible intrinsic renal failure: A preliminary communication. Scott Med J 1974; 19(Suppl 1):35-39
65. Cantarovich F, Fernandez JC, Locatelli A, et al: Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J 1971; 47(Suppl):13-17
66. Cantarovich F, Galli C, Benedetti L, et al: High dose frusemide in established acute renal failure. BMJ 1973; 4:449-450
67. Cantarovich F, Rangoonwala B, Lorenz H, et al: High-dose furosemide for established ARF: A prospective, randomized, doubleblind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004; 44:402-409
68. Chandra M, Agarwal SS, Mitra MK, et al: Some observations in the management of acute renal failure by massive intravenous frusemide therapy. J Assoc Physicians India 1975; 23:415-422
69. Chandra M, Agarwal SS, Mitra NK, et al: Massive intravenous frusemide therapy in acute renal failure. J Indian Med Assoc 1975; 64:47-48
70. Karayannopoulos S: High-dose frusemide in renal failure. BMJ 1974; 2:278-279
71. Kleinknecht D, Ganeval D, Gonzalez-Duque LA: Furosemide in acute oliguric renal failure: A controlled trial. Nephron 1976; 17:51-58
72. Lucas CE, Zito JG, Carter KM, et al: Questionable value of furosemide in preventing renal failure. Surgery 1977; 82:341-320
73. Lumlertgul D, Keoplung M, Sitprija V, et al: Furosemide and dopamine in malarial acute renal failure. Nephron 1989; 52:40-44
74. Minuth AN, Terrell JB Jr, Suki WN: Acute renal failure: A study of the course and prognosis of 104 patients and of the role of furosemide. Am J Med Sci 1976; 271:317-324
75. Seedat YK: High dose frusemide in established acute renal failure. BMJ 1973; 4:784
76. Shilliday IR, Quinn KJ, Allison ME: Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12:2592-2596
77. Sirivella S, Gielchinsky I, Parsonnet V: Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000; 69:501-506
78. Vargas Hein O, Staegemann M, Wagner D, et al: Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients. Ren Fail 2005; 27:385-392
79. Zito J, Cortez A, Lucas CE, et al: Distribution of renal blood flow after furosemide in critically ill patients. Surg Forum 1976; 27:27-29
80. Uchino S, Bellomo R, Morimatsu H, et al: Continuous renal replacement therapy: A worldwide practice survey. The Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007; 33:1563-1570
81. Kellum JA: Diuretics in acute renal failure: Protective or deleterious. Blood Purif 1997; 15:319-322
82. Kellum JA: Use of diuretics in the acute care setting. Kidney Int Suppl 1998; 66:S67-S70
83. Lameire N, Vanholder R, Van Biesen W: Loop diuretics for patients with acute renal failure: Helpful or harmful? JAMA 2002; 288:2599-2601
84. Noble DW: Acute renal failure and diuretics: Propensity, equipoise, and the need for a clinical trial [comment]. Crit Care Med 2004; 32:1794-1795
85. Schetz M: Diuretics in acute renal failure? Contrib Nephrol 2004; 144:166-181
86. Schetz M: Should we use diuretics in acute renal failure? Best Pract Res Clin Anaesthesiol 2004; 18:75-89
87. Ho KM, Sheridan DJ: Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333:420
88. Bagshaw SM, Delaney A, Bellomo R: Equipoise on whether frusemide can improve outcome in acute renal failure. BMJ [Rapid Responses] August 2, 2006. Available at: http://www.bmj.com/cgi/eletters/333/7565/420#138876
89. Bagshaw SM, Delaney A, Haase M, et al: Loop diuretics in the management of acute renal failure: A systematic review and metaanalysis. Crit Care Resusc 2007; 9:68
90. Bagshaw SM, Mortis G, Godinez-Luna T, et al: Renal recovery after severe acute renal failure. Int J Artif Organs 2006; 29:1023-1030
91. Gettings LG, Reynolds HN, Scalea T: Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999; 25:805-813
92. Liu KD, Himmelfarb J, Paganini E, et al: Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006; 1:915-919
93. Bellomo R: The epidemiology of acute renal failure: 1975 versus 2005. Curr Opin Crit Care 2006; 12:557-560
94. Sampath S, Moran JL, Graham PL, et al: The efficacy of loop diuretics in acute renal failure: Assessment using Bayesian evidence synthesis techniques. Crit Care Med 2007; 35:2516-2524